Cargando…

In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival

Chromosomal abnormalities in plasma cells (PCs) from multiple myeloma (MM) provide a clonal signature to identify malignant cells. BM-lymphocytes from MM aspirates, defined by stringent criteria, were screened for the same chromosomal abnormalities as autologous PCs, including translocations, deleti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marun, Carina S Debes, Belch, Andrew R, Pilarski, Linda M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Subscription Services, Inc., A Wiley Company 2012
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433796/ https://www.ncbi.nlm.nih.gov/pubmed/22495885 http://dx.doi.org/10.1002/ajh.23194

Ejemplares similares

Frequent Occurrence of Highly Expanded but Unrelated B-Cell Clones in Patients with Multiple Myeloma
por: Kriangkum, Jitra, et al.
Publicado: (2013)

Alteration of Introns in a Hyaluronan Synthase 1 (HAS1) Minigene Convert Pre-Mrna Splicing to the Aberrant Pattern in Multiple Myeloma (MM): MM Patients Harbor Similar Changes
por: Kriangkum, Jitra, et al.
Publicado: (2013)

Correction: Alteration of Introns in a Hyaluronan Synthase 1 (HAS1) Minigene Convert Pre-mRNA Splicing to the Aberrant Pattern in Multiple Myeloma (MM): MM Patients Harbor Similar Changes
por: Kriangkum, Jitra, et al.
Publicado: (2013)

In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival
por: Thulien, Kyle J, et al.
Publicado: (2012)

Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist During Treatment with Rituximab
por: Pilarski, Linda M., et al.
Publicado: (2008)

The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma
por: Zheng, Mary M., et al.
Publicado: (2013)

Durable Leukemic Remission and Autologous Marrow Recovery with Random Chromosomal Abnormalities after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
por: Nishikii, Hidekazu, et al.
Publicado: (2019)

Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities
por: Kriegova, Eva, et al.
Publicado: (2021)

Abnormal bone marrow microenvironment: the “harbor” of acute lymphoblastic leukemia cells
por: Chen, Zehui, et al.
Publicado: (2021)

Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma
por: Kim, Miyoung, et al.
Publicado: (2016)

Chromosome 1q21 abnormalities in multiple myeloma
por: Schmidt, Timothy M., et al.
Publicado: (2021)

Hyperdiploid Multiple Myeloma with Novel Complex Structural Chromosome Abnormalities Associated with Poor Prognosis : A Rare Case Report
por: Ankathil, Ravindran, et al.
Publicado: (2021)

Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma
por: Xia, Yuan, et al.
Publicado: (2022)

Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia
por: Kriangkum, Jitra, et al.
Publicado: (2015)

Predictive Value of Post-Transplant Bone Marrow Plasma Cell Percent in Multiple Myeloma Patients Undergone Autologous Transplantation
por: Hwang, In Hye, et al.
Publicado: (2011)

Total Marrow Irradiation as Part of Autologous Stem Cell Transplantation for Asian Patients with Multiple Myeloma
por: Lin, Shih-Chiang, et al.
Publicado: (2013)

Multiple Myeloma Immunophenotype Related to Chromosomal Abnormalities Used in Risk Assessment
por: Radzevičius, Mantas, et al.
Publicado: (2022)

Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients
por: Bieghs, Liesbeth, et al.
Publicado: (2016)

Combined Use of Autologous Bone Marrow-derived Stem Cells and Platelet-rich Plasma for Ovarian Rejuvenation in Poor Responders
por: Tandulwadkar, Sunita, et al.
Publicado: (2020)

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
por: Corre, Jill, et al.
Publicado: (2020)

Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma
por: Crabtree, Matthew, et al.
Publicado: (2022)

Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
por: Zdzisińska, Barbara, et al.
Publicado: (2008)

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients
por: Walker, B A, et al.
Publicado: (2014)

Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis
por: Jiang, Chi-yi, et al.
Publicado: (2021)

Coexistence of chronic lymphocytic leukemia and multiple myeloma, do the roots of these entities originate from the same place?
por: Merdin, Alparslan, et al.
Publicado: (2017)

Chronic lymphocytic leukemia-associated chromosomal abnormalities and miRNA deregulation
por: Kiefer, Yvonne, et al.
Publicado: (2012)

A Rare Chromosomal Abnormality in Chronic Lymphocytic Leukemia: t(13;13)
por: Safaei, Akbar, et al.
Publicado: (2020)

Development of plasma cell myeloma in a B-cell chronic lymphocytic leukemia patient with chromosome 12 trisomy
por: Pereira, Welbert de Oliveira, et al.
Publicado: (2013)

Evaluation of chromosomal abnormalities by clg-FISH and association with proliferative and apoptotic indexes in multiple myeloma
por: Linardi, C.C.G., et al.
Publicado: (2012)

Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma
por: Luo, Tiancheng, et al.
Publicado: (2020)

Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma
por: Locher, Maurus, et al.
Publicado: (2022)

Autophagy-related genes affect the survival of multiple myeloma patients depending on chromosomal abnormality
por: Ayna Duran, Gizem, et al.
Publicado: (2023)

The Effect of Belantamab Mafodotin on Primary Myeloma–Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells
por: Matula, Zsolt, et al.
Publicado: (2023)

Autologous Platelet-Poor Plasma Gel for Injection Laryngoplasty
por: Woo, Seung Hoon, et al.
Publicado: (2013)

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
por: Binder, M, et al.
Publicado: (2017)

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
por: Shi, Lihui, et al.
Publicado: (2016)

Bone Marrow Gouty Tophi With Plasma Cell Myeloma
por: Bang, Hae In, et al.
Publicado: (2020)

Bone Marrow Plasma Cell Assessment before Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
por: Lee, Sung-Eun, et al.
Publicado: (2014)

Lymphocyte transformation induced by autologous cells. IV. Human T- lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes
Publicado: (1976)

High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
por: Barnett, M. J., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_gji2cg6mdljc1895sclhbc140m